期刊文献+

糖尿病心脏自主神经病变及α-硫辛酸治疗的研究进展 被引量:2

下载PDF
导出
摘要 流行病学调查显示,约20%~50%的糖尿病患者合并有自主神经病变(CAN),其中心脏自主神经病变是最严重的并发症之一。研究报道,CNA在1型糖尿病患者中的发病率为17%,在2型糖尿病患者中的发病率为22%。临床表现为运动耐受性不良,直立性低血压,严重出现静息持续性窦性心动过速,无症状性心肌缺血,无痛性心肌梗死,甚至心脏性猝死等。很多流行病学资料表明,5年内的死亡率达50%,主要以迷走神经损害为主,从而导致患者心脏性猝死的危险性增加。
出处 《实用糖尿病杂志》 2014年第5期60-61,共2页 Journal of Practical Diabetology
基金 云南省卫生科技内设研究机构项目(编号:2011ws0011)
  • 相关文献

参考文献16

  • 1Callaghan BC, Cheng HT, Stable CL, et al. Diabetic neuropathy:clinicla manifestations and current treatments. Lancet Neurol 2012 ; 11:521 - 534.
  • 2Maser RE, Lenhard MJ, Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences and treatment. The Journal of Clinical Endocrinology Metabolism 2005 ; 90(10) :5896 -5903.
  • 3Vinik AI, Maser RE, Mitchell BD, et al. Diabetic Autonomic Neuropathy. Diabetes Care 2003 ;26 (5) : 1553 - 1579.
  • 4Schonauer M, Thomas A, Morbach A, et al. Cardiac autonom- ic diabetic neuropathy. Diabetes and Vasuclar Disease Research 2008 ;5 (4) : 336 - 344.
  • 5Nayak UB, Acharya A, Jain H, et al. Clinical assessment of the autonomic nervous system in diabetes mellitus and its correlation with glycemic control. Indian Journal of Medical Sciences 2003 ; 67 (1 -2) :13 -22.
  • 6Khoharo HK, Halepoto AW. QTc-interval, heart rate variabili- ty and postural hypotension as an indicator of cardiac autonomic neu- ropathy in type 2 diabetei patients. J Pak Med Assoc 2002 ; 62 (4) .. 328 - 331.
  • 7Refaie W. Assessment of cardiac autonomic neuropathy in long standing type 2 diabetic women. The Egyptian Heait Journal 2013;2(6) :1 -7.
  • 8牛奔,苏恒,张云,薛元明.糖尿病心脏自主神经病变与周围感觉神经损伤的关系探讨[J].实用糖尿病杂志,2009,5(5):23-24. 被引量:2
  • 9Sacre JW, Jellis CL, Marwick TH, et al. Relibility of heart rate variability in patients with type 2 diabetes mellitus. Dibetic Medicine 2011 : e33 - e40.
  • 10Xhyheri B, Manfrini O, Mazzoliniet M, et al. Heart rate varia- bility today. Progressin Cardiovascular Diseases 2012 ;55:321 -331.

二级参考文献9

共引文献1

同被引文献41

  • 1林令华,许金华,孟凡霞,李志改,于军会,杨华.依帕司他对糖尿病患者心率变异性影响的评价[J].中国医院用药评价与分析,2006,6(5):274-276. 被引量:3
  • 2黄雌友,姚伟峰,陈一丁,钱铁镛,万惠,吴卫国.α-硫辛酸治疗糖尿病自主神经病变的临床研究[J].齐齐哈尔医学院学报,2007,28(19):2314-2315. 被引量:3
  • 3Fusco F,Razzoli E,Imbimbo C,et al.A new era in the treatment of erectile dysfunction:chronic phosphodiesterase type 5 inhibition.BJU Int,2010,105(12):1634-1639.
  • 4González-Corrochano R,La Fuente J,Cuevas P,et al.Ca2+-activated K+channel(KCa)stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.Br J Pharmacol,2013,169(2):449-461.
  • 5Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy[J]. Diabetes Care, 2013,26 ( 5 ) : 1553-1579.
  • 6Oakley I, Emond L. Diabetic cardiac autonomic neuropathy and anesthetic management: review of the literature[J]. AANA J, 2011,79 (6) :473-479.
  • 7Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as compli- cations of diabetes mellitus[J]. Nat Rev Endocrinol, 2012,8 (7) : 405-416.
  • 8Hu X, Li S,Yang G, et al. Efficacy and safety of aldose reductase inhibitor for the treatment of diabetic cardiovascular autonomic neuropathy : syste- matic review and recta-analysis[J]. PLoS One, 2014,9 (2) : e87096.
  • 9Ikeda T,Iwata K,Tanaka Y. Long-term effect of epalrestat on cardiac au- tonomic neuropathy in subjects with non-insulin dependent diabetes mel- litus[J]. Diabetes Res Clin Pract, 1999,43 (3) : 193-198.
  • 10Ziegler D,Schatz H, Conrad F, et al. Effects of treatment with the antioxi- dam alpha-lipoic acid on cardiac autonomic neuropathy in NIDI)M patients. A 4-month randomized controlled multicenter trim (DEKAN Study). Deu- tsche kardiale autonome neuropathie [J]. Diabetes Care, 1997,20 (3):369- 373.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部